Abstract S6-01: BRCA1 methylation status, silencing and treatment effect in the TNT trial: A randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012)
Year: 2017
Type: conference-abstract
Source: Cancer Research
Authors: A Tutt, MCU Cheang, L Kilburn, H Tovey, C Gillett, S Pinder, J Lanchbury, J Abraham, S Barrett, P Barrett-Lee, S Chan, P Gazinska, A Grigoriadis, S Kernaghan, K Hoadley, A Gutin, C Harper-Wynne, M Hatton, J Owen, P Parker, R Roylance, A Shaw, I Smith, R Thompson, K Timms, A Wardley, G Wilson, M Harries, P Ellis, A Ashworth, C Perou, J Bliss, N Rahman, R Brown, On Behalf of the TNT Trial Management Group and Investigators
Institutions: University of North Carolina at Chapel Hill, Royal Marsden NHS Foundation Trust, Nottingham University Hospitals NHS Trust, University College London Hospitals NHS Foundation Trust, Institute of Cancer Research, Maidstone and Tunbridge Wells NHS Trust, King's College London, Guy's and St Thomas' NHS Foundation Trust, Velindre NHS Trust, Breast Cancer Now, Beatson West of Scotland Cancer Centre, The Francis Crick Institute, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Marsden Hospital, The Christie NHS Foundation Trust, Velindre Cancer Centre, Myriad Genetics, UCSF Helen Diller Family Comprehensive Cancer Center, UNC Lineberger Comprehensive Cancer Center, Imperial College London
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2593021153